Results 241 to 250 of about 79,824 (366)

Blood eosinophil reference values and determinants in a representative adult population. [PDF]

J Allergy Clin Immunol Glob
Abohalaka R, Ercan S, Lehtimäki L, Özuygur Ermis SS, Lisik D, Bashir Awad Bashir M, Jadhav R, Ekerljung L, Wennergren G, Lötvall J, Pullerits T, Backman H, Rådinger M, Nwaru BI, Kankaanranta H.   +14 more
europepmc   +1 more source

Maternal age at menarche and atopy among offspring at the age of 31 years [PDF]

, 2000
Bo Xu
openalex   +1 more source

Adult Vulval Psoriasis: Clinical Presentation, Management and Impact on Quality of Life

Australasian Journal of Dermatology, Volume 66, Issue 4, Page e209-e216, June 2025.
ABSTRACT Background/Objectives To explore the clinical presentation, management and impact on quality of life in women with vulval psoriasis. Methods A retrospective, single‐centre cohort study of women was conducted at a large dermatology practice from January 2016 to January 2024.
Michelle Wu, Gayle Fischer
wiley   +1 more source

Allergens in modern society: 2021

Allergology International, 2021
Toshiro Takai
doaj  

Association between herpes zoster ophthalmicus and the risk of corneal ulcer. [PDF]

Front Med (Lausanne)
Weng SF, Chang YS, Wang JJ, Jan HY, Chen JY, Tseng SH, Jan RL.   +6 more
europepmc   +1 more source

Similar prevalence of respiratory symptoms and atopy in Estonian schoolchildren with changing lifestyle over 4 yrs [PDF]

, 2000
M.‐A. Riikjärv, Triine Annus, Lennart Bråbäck, Mati Rahu, Bengt Björkstén   +4 more
openalex   +1 more source

Circulating Th2 memory cells in IgG4‐related disease are restricted to a defined subset of subjects with atopy

Allergy. European Journal of Allergy and Clinical Immunology, 2014
H. Mattoo, E. Della-Torre, E. Della-Torre, V. Mahajan, J. Stone, S. Pillai   +5 more
semanticscholar   +1 more source

Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma

Allergy, Volume 80, Issue 6, Page 1669-1676, June 2025.
This study analyzed the clinical and biomarker data from 175 adults with severe asthma treated with the anti‐TSLP monoclonal antibody tezepelumab. Following tezepelumab initiation, the exacerbation rate decreased, with 59% of patients remaining exacerbation‐free at 1 year. Asthma symptom control as measured by ACQ‐6 significantly improved after 4 weeks
Jessica Gates, Faizan Haris, Francesca Cefaloni, Paniz Khooshemehri, Linda Green, Mariana Fernandes, Louise Thomson, Cris Roxas, Jodie Lam, Grainne d'Ancona, Alexandra M. Nanzer, Jaideep Dhariwal, David J. Jackson   +12 more
wiley   +1 more source

Microbiome and pediatric leukemia, diabetes, and allergies: Systematic review and meta-analysis. [PDF]

PLoS One
Gallant R, Reza S, Wiemels JL, Greaves M.   +3 more
europepmc   +1 more source

Variation in the Interleukin 4–Receptor α Gene Confers Susceptibility to Asthma and Atopy in Ethnically Diverse Populations [PDF]

, 2000
Carole Ober, Stephanie A. Leavitt, Anya Tsalenko, Timothy D. Howard, Danessa M. Hoki, Rajeev Daniel, Dina L. Newman, Xiaodong Wu, Rodney Parry, Lucille A. Lester, Julian Solway, Malcolm N. Blumenthal, Richard A. King, Jianfeng Xu, Deborah A. Meyers, Eugene R. Bleecker, Nancy J. Cox   +16 more
openalex   +1 more source